Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome
Nogueira-Castañon, M.C.; Pereira, C.A.; Furtado, T.
International Journal of Dermatology 35(4): 295-297
1996
ISSN/ISBN: 0011-9059 PMID: 8786193 Document Number: 459719
Document emailed within 1 workday
Related Documents
Gelanew, T.; Hurissa, Z.; Diro, E.; Kassahun, A.; Kuhls, K.; Schönian, G.; Hailu, A. 2011: Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia American Journal of Tropical Medicine and Hygiene 84(6): 906-912Pourahmad, M.; Hooshmand, F.; Rahiminejad, M. 2009: Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS) International Journal of Dermatology 48(1): 59-61
Ndiaye, P.B.; Develoux, M.; Dieng, M.T.; Huerre, M. 1996: Diffuse cutaneous leishmaniasis and acquired immunodeficiency syndrome in a Senegalese patient Bulletin de la Societe de Pathologie Exotique 89(4): 282-286
Convit, J.; Ulrich, M. 1993: Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis Biological Research 26(1-2): 159-166
Franco-Vicario, R.; Beltrán de Heredia, J.M.; Rojo, P.; Hermosa, C. 1987: Leishmaniasis associated with acquired immunodeficiency syndrome Medicina Clinica 88(14): 565-566
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to acquired immunodeficiency syndrome associated virus in sera from acquired immunodeficiency syndrome related complex and japanese hemophiliacs infected with acquired immunodeficiency syndrome associated virus Microbiology and Immunology 29(11): 1083-1088
Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Rosenberg, J.D.; Scheinfeld, N.S. 2003: Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome Cutis 72(6): 439-445
Aguado, J.M.; Echevarría, S. 1989: Trichomegaly: an unusual manifestation of acquired immunodeficiency syndrome? Medicina Clinica 93(18): 715-716
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.; Kirkpatrick, C.H. 1986: Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome Cancer Research 46(5): 2557-2561
Colebunders, R.; Izaley, L.; Bila, K.; Kabumpangi, K.; Melameka, N.; Francis, H.; Curran, J.W.; Ryder, R.; Piot, P. 1987: Cutaneous reactions to trimethoprim-sulfamethoxazole in African patients with the acquired immunodeficiency syndrome Annals of Internal Medicine 107(4): 599-600
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Walton, B.C.; Paulson, J.E.; Arjona, M.A.; Peterson, C.A. 1974: American cutaneous leishmaniasis. Inefficacy of metronidazole in treatment JAMA 228(10): 1256-1258
Castés, M.; Agnelli, A.; Rondón, A.J. 1984: Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis Clinical and Experimental Immunology 57(2): 279-286
Ulrich, M.; Centeno, M.; Mattout, Z.; Convit, J. 1988: Serological patterns and specificity in American cutaneous leishmaniasis American Journal of Tropical Medicine and Hygiene 39(2): 179-184
Arzubiaga, C.; Huayanay, J.; Biaggioni, I. 1984: Epidemiological study of American cutaneous leishmaniasis in Maypuco, Peru Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 96(5): 417-424
Chiari, C.de.A.; Mayrink, W.; Magalhães, P.A. 1973: Indirect immunofluorescent reaction in the control and treatment of American cutaneous leishmaniasis Revista do Instituto de Medicina Tropical de Sao Paulo 15(5): 298-303
Oster, C.N.; Chulay, J.D.; Hendricks, L.D.; Pamplin, C.L.; Ballou, W.R.; Berman, J.D.; Takafuji, E.T.; Tramont, E.C.; Canfield, C.J. 1985: American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules American Journal of Tropical Medicine and Hygiene 34(5): 856-860
Reithinger, R.; Espinoza, J.Canales.; Davies, C.R. 2003: The transmission dynamics of canine American cutaneous leishmaniasis in Huánuco, Peru American journal of tropical medicine and hygiene 69(5): 473-480
Modlin, R.L.; Tapia, F.J.; Bloom, B.R.; Gallinoto, M.E.; Castes, M.; Rondon, A.J.; Rea, T.H.; Convit, J. 1985: In situ characterization of the cellular immune response in American cutaneous leishmaniasis Clinical and Experimental Immunology 60(2): 241-248